Description:

Cyclophosphamide and Doxorubicin (CA x 4 cycles) versus Paclitaxel (4 cycles) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Lymph Nodes: A 2x2 Factorial Phase III Randomized Study Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=36B8E5A6-BC9A-573E-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=36B8E5A6-BC9A-573E-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
  4. 9/17/21
Uploaded on:

September 17, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00041119 Registration - CALGB 40101 REGISTRATION WORKSHEET - 2670720v1.0

No Instruction available.

  1. StudyEvent: CALGB 40101 REGISTRATION WORKSHEET
    1. No Instruction available.
Header Module
Protocol Administration
Patient Demographics/pre-treatment Characteristics
Gender
Race (Mark all that apply)
Ethnicity (Mark one)
ECOG Performance Status
cm
Kg
m2
Method of Payment
Certification Of Eligibility And Protocol Design
In the opinion of the investigator, is the patient eligible?
Menopausal status
ER/PgR
HER-2/neu status
Assigned Treatment Arm
Initial Patient Consent For Specimen Use
Is the patient registering to the Pharmacogenetic companion study 60202 (titled "Drug Metabolism and Transport PG in Breast CA")?
Patient's initial consent given for blood specimen use for genetic research on patient's cancer?
Did patient consent to DNA specimen use in future research studies?
Patient's Initial Consent given for tissue specimen use for research on the patient's cancer?
Patient's Initial Consent given for tissue specimen use for research unrelated to the patient's cancer?
Patient's initial consent given for further contact regarding specimen?
Registration Information

Similar models